Virtus LifeSci Biotech Products ETF (BBP)

Assets	$25.24M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	400,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+9.77%

Volume	1,278
Open	65.68
Previous Close	64.38
Day's Range	65.68 - 66.43
52-Week Low	48.65
52-Week High	69.12
Beta	0.56
Holdings	57
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

23.57% of assets

Name	Symbol	Weight
Rhythm Pharmaceuticals, Inc.	RYTM	2.63%
Ardelyx, Inc.	ARDX	2.55%
Alnylam Pharmaceuticals, Inc.	ALNY	2.51%
Aurinia Pharmaceuticals Inc.	AUPH	2.44%
Mirum Pharmaceuticals, Inc.	MIRM	2.36%
CRISPR Therapeutics AG	CRSP	2.36%
Ligand Pharmaceuticals Incorporated	LGND	2.26%
Apellis Pharmaceuticals, Inc.	APLS	2.18%
Tarsus Pharmaceuticals, Inc.	TARS	2.15%
BridgeBio Pharma, Inc.	BBIO	2.14%